The Fondazione Leonardo is supporting the implementation of CASE BioMed's training programs on Monte Verità over a three-year period from 2026 to 2028.
The new Bio- and MedTech Business Program will take place from November 8-13, 2026. The number of participants is limited to 20. To register, please contact Dr. Heidrun Flaadt, Heidrun.Flaadt@usi.ch.
This textbook helps emerging business ideas in the field of eHealth to understand and develop the keys to success.
BioVersys AG, a spin-off from ETH Zurich founded by BioBusiness2010 alumnus Dr. Marc Gitzinger, has completed its Initial Public Offering (IPO) on February 7, 2025, on the SIX Swiss Exchange.
This is by far the best program I have ever attended. It gave me the courage to go the way with my company. The quality of the speakers is world class. The organization and minds behind the program are brilliant. This changed my perception of USI as important player in education of entrepreneurs.
